ALRN
Aileron Therapeutics Inc
Halal Rating :
Last Price
$1.79
Last updated:
Market Cap
-
7D Change
-6.77%
1 Year Change
-44.58%
Company Overview
Industries
Exchange
Next Earnings Date
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics for various diseases, with a primary focus on cancer treatments. The company is developing stabilized, cell-permeating peptides that address key intracellular targets in cancer and other diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Aileron Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.